| Child | Adult | |
|---|---|---|
| Tmax | 0.75 hours | 1.2 hours |
| T½ | somewhat longer than the adult values | 6-7 hours |
No information is present at this moment.
No information is present at this moment.
| Sickle cell anaemia |
|---|
Creatinine clearance 30-60 ml/min: 50% of the dose
Creatinine clearance < 30 ml/min: do not use
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
In children, the side effect profile is similar to that in adults. However, neutropenia was more common in children aged 2–10 years, and dry skin, alopecia, headache and anemia were less common than in adults. In children aged 10–18 years, dry skin, skin ulcer, alopecia, weight gain and anemia were less common than in adults.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific warnings and precautions in children.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Methylhydrazines | ||
|---|---|---|
| L01XB01 | ||
| PROTEINEKINASEREMMERS | ||
|---|---|---|
| L01XE06 | ||
| L01XE01 | ||
| Other antineoplastic agents | ||
|---|---|---|
| L01XX02 | ||
| L01XX24 | ||